<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The risk of bias and quality of preclinical 
 <italic class="italic">in vivo</italic> studies were performed using an adapted checklist [
 <xref rid="B21" ref-type="bibr" class="xref">21</xref>â€“
 <xref rid="B23" ref-type="bibr" class="xref">23</xref>]. This investigation allowed assessing the methodological quality of the included studies concerning mainly the randomization of the treatment allocation, blinded drug administration, blinded outcome assessment, and outcome measurements.
</p>
